Annals of Oncology Advance Access published online on November 4, 2009
Annals of Oncology, doi:10.1093/annonc/mdp469
© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
letter to the editor |
Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?
| The first 10% of the full text of this article appears below. |
We have read with great interest the meta-analysis reported by Okines et al. [1] comparing capecitabine-based and 5-fluorouracil-based combination chemotherapy in advanced gastric cancer (AGC) and we completely agree with the authors conclusion that capecitabine can substitute 5-fluorouracil in this setting. Moreover, as the analysis demonstrates a significant
1 Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori
2 Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, Pisa, Italy
* (E-mail: envasile@tin.it)